© Copyright 2016 IP Research Consulting. All right reserved.
Navigation Menu

News, events &

publications

Find all our news here

15-16 June 2016: Synergy Meeting of FP7-HEALTH- 2013-2.2.4-2 - Drug Development for Neglected Parasitic Diseases, Modena, Italy. 14 June 2016: KINDReD Meeting, Modena, Italy. 15-18 May 2016, World Medicine Park, Mykonos, Greece: Presentation 'Activomics Biomarkers for the stratification of chrinic low back pain'. Iain Pemberton, Research director, Photeomix. 7,8 & 9 April 2016 - Rome, Italy: Presentation “Activomics as new biomarker for discogenic pain”. Iain Pemberton, Research director, Photeomix.
More information available soon.

Photeomix

beneficiary of

EU H2020-

SMEINST-1-

2015

Transferring Activomics into the Clinical Setting (TACTICS). Advancing our proprietary biomarker discovery tool, Activomics, into the clinical laboratory represents an exciting milestone in the introduction of this disruptive technology to the global diagnostics market.
© Copyright 2016 IP Research Consulting. All right reserved.
Home About Science & Technology Activomics Get involved Activomics-store Partners News Contact

News, events &

publications

Find all our news here

15-16 June 2016: Synergy Meeting of FP7-HEALTH-2013- 2.2.4-2 - Drug Development for Neglected Parasitic Diseases, Modena, Italy. 14 June 2016: KINDReD Meeting, Modena, Italy. 15-18 May 2016, World Medicine Park, Mykonos, Greece: Presentation 'Activomics Biomarkers for the stratification of chrinic low back pain'. Iain Pemberton, Research director, Photeomix. 7,8 & 9 April 2016 - Rome, Italy: Presentation “Activomics as new biomarker for discogenic pain”. Iain Pemberton, Research director, Photeomix.

Photeomix

beneficiary of

EU H2020-

SMEINST-1-

2015

Transferring Activomics into the Clinical Setting (TACTICS). Advancing our proprietary biomarker discovery tool, Activomics, into the clinical laboratory represents an exciting milestone in the introduction of this disruptive technology to the global diagnostics market.
News